Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Avacopan may cause unexpected side effects, so early monitoring is important.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

Early remdesivir treatment improves outcomes in Covid-19 patients with few side effects.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

Tangent screens help detect visual field defects from vigabatrin.

Five FDA-approved drugs may help block COVID-19 virus entry.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The treatment cleared psoriasis in some patients but caused side effects in most.

The combination of encorafenib and binimetinib caused few skin issues.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

34% of patients on hepatitis C treatment had reversible skin issues.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Early diagnosis and treatment of Kaposi varicelliform eruption are crucial to prevent severe complications.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.